Publications (1)0 Total impact
-
Conference Proceeding: Validation of a custom 512-gene breast cancer panel on the illumina-based DASL mRNA expression platform: focus on triple negative breast tumors using RNA from stored formalin-fixed, paraffin blocks
31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX; 01/2008